PROactive study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
PROactive study. / Gaede, Peter; Parving, Hans-Henrik; Pedersen, Oluf.
In: Lancet, Vol. 367, No. 9504, 2006, p. 23-4; author reply 26-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Gaede, P, Parving, H-H & Pedersen, O 2006, 'PROactive study', Lancet, vol. 367, no. 9504, pp. 23-4; author reply 26-7. https://doi.org/10.1016/S0140-6736(06)67912-9
APA
Gaede, P., Parving, H-H., & Pedersen, O. (2006). PROactive study. Lancet, 367(9504), 23-4; author reply 26-7. https://doi.org/10.1016/S0140-6736(06)67912-9
Vancouver
Gaede P, Parving H-H, Pedersen O. PROactive study. Lancet. 2006;367(9504):23-4; author reply 26-7. https://doi.org/10.1016/S0140-6736(06)67912-9
Author
Bibtex
@article{b72df63e35974b13b2ea85acb1d78b31,
title = "PROactive study",
keywords = "Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Endpoint Determination, Humans, Hypoglycemic Agents, Risk, Thiazolidinediones",
author = "Peter Gaede and Hans-Henrik Parving and Oluf Pedersen",
year = "2006",
doi = "10.1016/S0140-6736(06)67912-9",
language = "English",
volume = "367",
pages = "23--4; author reply 26--7",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "9504",
}
RIS
TY - JOUR
T1 - PROactive study
AU - Gaede, Peter
AU - Parving, Hans-Henrik
AU - Pedersen, Oluf
PY - 2006
Y1 - 2006
KW - Blood Pressure
KW - Cholesterol
KW - Diabetes Mellitus, Type 2
KW - Endpoint Determination
KW - Humans
KW - Hypoglycemic Agents
KW - Risk
KW - Thiazolidinediones
U2 - 10.1016/S0140-6736(06)67912-9
DO - 10.1016/S0140-6736(06)67912-9
M3 - Journal article
C2 - 16399142
VL - 367
SP - 23-4; author reply 26-7
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 9504
ER -
ID: 38455648